Clinical Trials Directory

Trials / Conditions / Head Pain

Head Pain

14 registered clinical trials studyying Head Pain — 2 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDifferent Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries
NCT07155109
Diskapi Yildirim Beyazit Education and Research HospitalN/A
UnknownInfluenCEF Study: Study on the Headache Associated With Influenza Infection
NCT05704335
Hospital Clínico Universitario de Valladolid—
UnknownEffect of Exercises on Computer Vision Syndrome
NCT05414799
Shifa Tameer-e-Millat UniversityN/A
RecruitingIntravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department
NCT05325580
University of MonastirPhase 3
CompletedMasticatory Muscles Electromyography in Post-pubertal Females With Forward Head Posture and Temporomandibular
NCT05712655
Cairo University—
UnknownQST, Blink Reflex and Nociceptive Flexion Reflex in Headache
NCT04585698
University of Liege—
CompletedCandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study
NCT04138316
Hospital Clínico Universitario de Valladolid—
UnknownAnti-CGRP Monoclonal Antibody Response After Switching (AMARAS)
NCT05785988
Hospital Clínico Universitario de Valladolid—
WithdrawnAnalgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain
NCT03869710
San Salvatore Hospital of L'AquilaN/A
CompletedAromatherapy Massage in Migraine Attacks
NCT04151576
Biruni UniversityN/A
CompletedCopeptin for Risk Stratification in Non-traumatic Headache in the Emergency Setting - The CoHead Study
NCT01174901
University Hospital, Basel, Switzerland—
CompletedDiaphragmatic Movement Before and After Stellate Ganglion Block : A Ultrasonographic Study
NCT01054378
Yonsei UniversityPhase 4
UnknownCervical Epidural Pressure Measurement
NCT01009385
Seoul National University Bundang HospitalN/A
CompletedA Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for th
NCT00297375
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Phase 4